2018
DOI: 10.1016/j.amjcard.2017.11.025
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Acute myocardial infarction is typically divided into ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction [ 13 ], while ST-segment elevation myocardial infarction is one of the essential causes of acute decompensated heart failure, with a mortality rate of 5% to 8% during hospitalization and a high readmission rate [ 14 ]. Recent studies have identified that the majority of patients with ST-segment elevation myocardial infarction have underlying diseases, with diabetes being a common underlying condition [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Acute myocardial infarction is typically divided into ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction [ 13 ], while ST-segment elevation myocardial infarction is one of the essential causes of acute decompensated heart failure, with a mortality rate of 5% to 8% during hospitalization and a high readmission rate [ 14 ]. Recent studies have identified that the majority of patients with ST-segment elevation myocardial infarction have underlying diseases, with diabetes being a common underlying condition [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Numerous studies have demonstrated that the method of revascularization had an impact on prognosis [22,23]. In the DANAMI-3-PRIMULTI trial of 1 countries and 627 patients, compared with FFR-guided functional CR, MVD-STEMI patients treated with IRA-only strategy (anatomical IR) had a 1.7-fold increase in 27-month MACE risk (22% vs 13%, P = 0.004), mainly including all-cause mortality, non-fatal reinfarction, and ischaemia-driven revascularisation [24].…”
Section: Diatebes and Fir And Macementioning
confidence: 99%
“…Major adverse cardiac events (MACE) for the purposes of follow-up were as follows: (1) acute myocardial infarction; (2) decompensated heart failure; (3) target vessel revascularization and (4) mortality due to cardiac disease [20].…”
Section: Angiographic Evaluationmentioning
confidence: 99%